Zobrazeno 1 - 10
of 190
pro vyhledávání: '"H H, Malluche"'
Autor:
M C Monier-Faugere, H H Malluche
Publikováno v:
Journal of the American Society of Nephrology. 4:1631-1642
Renal osteodystrophy is not a uniform disease. Therefore, knowledge of the underlying bone abnormalities is essential in deciding specific therapeutic regimens. To date, however, there is no unequivocal noninvasive means with which to define bone abn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43232bc0d6ca7563f9390314e2fc2dfa
https://doi.org/10.1681/asn.v491631
https://doi.org/10.1681/asn.v491631
Autor:
H H, Malluche, G A, Siami, C, Swanepoel, G H, Wang, H, Mawad, S, Confer, M, Smith, R D, Pratt, M-C, Monier-Faugere
Publikováno v:
Clinical nephrology. 70(4)
To investigate the evolution of renal osteodystrophy in patients on maintenance dialysis, treated with lanthanum carbonate (LC) vs. standard phosphate-binder therapy (Stx).This was a 2-year, randomized, prospective, open-label study during which pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bae42e05a070f2e8fe9477a2c2b8227d
https://pubmed.ncbi.nlm.nih.gov/18826853
https://pubmed.ncbi.nlm.nih.gov/18826853
Autor:
H H Malluche, T Freemont
Publikováno v:
University of Manchester-PURE
Scopus-Elsevier
Scopus-Elsevier
AIM: The aim of this study was to develop a novel approach to the analysis of bone histomorphometric data and outcomes presentation that would simplify the characterization of renal osteodystrophy and facilitate clinical decision-making. METHODS AND
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223d626e87b2e3c8ca86fbc0063db7bb
https://pubmed.ncbi.nlm.nih.gov/15730056
https://pubmed.ncbi.nlm.nih.gov/15730056
Publikováno v:
Calcium in Internal Medicine ISBN: 9781447111733
The macroscopic and microscopic characteristics of the organ “bone” are tightly related to its physiologic role in the body. The skeleton has a dual mechanical and metabolic function. The rigidity of the skeleton is responsible for maintenance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca9263a85b25a8a97a8795d412ff19a9
https://doi.org/10.1007/978-1-4471-0667-8_16
https://doi.org/10.1007/978-1-4471-0667-8_16
Autor:
K.-M. Koch, H. H. Malluche
Publikováno v:
Clinical Nephrology. 81:151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bde408987d5e1181e89d134cc0e3ba1
https://doi.org/10.5414/cnp81151
https://doi.org/10.5414/cnp81151
Publikováno v:
Clinical nephrology. 55(4)
Patients on hemodialysis may develop severe and symptomatic hypercalcemia if skeletal buffering is ineffective. We report a case of persistent hypercalcemia with apparent extrarenal vitamin D synthesis. Associated aluminium intoxication was suggested
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da0f9ad87c3604cb55db92e2094dc797
https://pubmed.ncbi.nlm.nih.gov/11334321
https://pubmed.ncbi.nlm.nih.gov/11334321
Autor:
H H, Malluche, M C, Monier-Faugère
Publikováno v:
Clinical nephrology. 54(4)
Control of serum phosphorus continues to be of utmost importance in renal replacement therapy, due to the high prevalence of hyperphosphatemia in the dialysis population. Hyperphosphatemia has traditionally been associated with secondary hyperparathy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3a21ffc3fced55b3c2dc41ff9ca8094
https://pubmed.ncbi.nlm.nih.gov/11076107
https://pubmed.ncbi.nlm.nih.gov/11076107
Publikováno v:
Clinical nephrology. 54(1)
Bisphosphonates (BP) are potent antiresorptive agents that have been used successfully in several bone diseases associated with hyperresorption. Hyperresorption, hypercalcemia, and osteoporosis are frequent findings in patients with renal failure or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d6b990e536f332572d08a22326a0dbd
https://pubmed.ncbi.nlm.nih.gov/10939756
https://pubmed.ncbi.nlm.nih.gov/10939756
Autor:
H H, Malluche, M C, Monier-Faugere
Publikováno v:
Clinical nephrology. 52(5)
Controlling serum phosphorus levels continues to be a challenge in patients with chronic renal disease. Hyperphosphatemia is implicated in the development and worsening of secondary hyperparathyroidism and renal osteodystrophy (ROD) through its effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8b35a67e2d6e2980a4d11c6da891ef1
https://pubmed.ncbi.nlm.nih.gov/10584989
https://pubmed.ncbi.nlm.nih.gov/10584989